Epidemiology and genetics of congenital heart diseases and cardiomyopathies in children;Épidémiologie et génétique des cardiopathies congénitales et des cardiomyopathies de l'enfant

Revue du Praticien

Volumn 56, Issue 6, 2006, Pages 599-604

  Bonnet, Damien ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CARDIOMYOPATHY; CHILD; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DELETION 22Q; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; EPIDEMIC; FAMILY; FATTY ACID OXIDATION; GENE IDENTIFICATION; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART SEPTUM DEFECT; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LYSOSOME STORAGE DISEASE; METABOLIC DISORDER; NOONAN SYNDROME; PHENOTYPE; RECURRENCE RISK; RESPIRATORY CHAIN; REVIEW; TRISOMY 21; VIRUS INFECTION; CONGENITAL HEART MALFORMATION; GENETICS;

CARDIOMYOPATHIES; HEART DEFECTS, CONGENITAL; HUMANS;

EID: 33645767437     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Samanek M. Congenital heart malformations: prevalence, severity, survival, and quality of life. Cardiol Young 2000;10:179-85.
2. Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999:99:916-8.
3. Grech V, Gatt M. Syndromes and malformations associated with congenital heart disease in a population-based study, Int J Cardiol 1999;68:151-6.
4. Ferencz C, Neill CA, Boughman JA, Rubin JD, Brenner JI, Perry LW. Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr 1989;114:79-86.
5. McElhinney DB, McDonald-McGinn D, Zackai EH, Goldmuntz E. Cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age. Pediatrics 2001;108:E104.
6. Marino B. Complete atrioventricular septal defect in patients with and without Down's syndrome. Ann Thorac Surg 1994;57:1687-8.
7. Stoll C, Garne E, Clementi M. EUROSCAN Study Group. Evaluation of prenatal diagnosis of associated congenital heart diseases by fetal ultrasonographic examination in Europe. Prenat Diagn 2001;21:243-52.
8. Nora JJ. Causes of congenital heart diseases: old and new modes, mechanisms and models. Am Heart J 1993;125:1409-19.
9. Clark EB. Mechanisms in the pathogenesis of congenital heart defects. In: Pierpont ME, Moller JM, eds. The genetics of cardiovascular diseases. Boston: Martinus-Nijoff, 1986:3-11.
10. Li QY, Newbury-Ecob RA, Terrett JA, et al. Holt-Oram syndrome is caused by mutations in TBX5 a member of the Brachyury (T) gene family. Nat Genet 1997;15:21-9.
11. Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998;281:108-11.
12. Satoda M, Zhao F, Diaz GA, et al. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus areriosus. Nat Genet 2000;25:42-6.
13. Ruiz-Perez VL, Ide SE, Strom TM, et al. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet 2000;24:283-6.
14. Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001;29:465-8.
15. Megarbane A, Salem N, Stephan E, et al. X-linked transposition of the great arteries and incomplete penetrance among males with a nonsense mutation in ZIC3. Eur J Hum Genet 2000;8:704-8.
16. Lindsay EA, Botta A, Jurecic V, et al. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 1999;401:379-83.
17. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-55.
18. Bonnet D, de Lonlay P, Gautier I, et al. Efficiency metabolic screening in childhood cardiomyopathies. Eur Heart J 1998;19:790-3.